Sasha Damouni | VP, IR and Corporate Communications |
Dr. Scott Braunstein | Chief Executive Officer |
Dr. Joe Hulihan | Chief Medical Officer |
Kimberly McCormick | Senior Vice President of Regulatory Affairs |
Christy Shafer | Chief Commercial Officer |
Steve Pfanstiel | Chief Financial Officer |
Joseph Thome | Cowen & Company |
Marc Goodman | SVB Leerink |
Douglas Tsao | H.C. Wainwright |
Andrew Tsai | Jefferies |
Jay Olson | Oppenheimer |
Brian Skorney | Baird |
Greetings, and welcome to the Marinus Pharmaceuticals Approval for Quarter and Full Year 2021 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] And now, it is my pleasure to introduce your host, Sasha Damouni, Vice President of Corporate Affairs and Investor Relations.
You may begin.